Allergan Tops 4Q Forecasts For Revenue, Adjusted Profit
February 10 2020 - 7:46AM
Dow Jones News
By Micah Maidenberg
Allergan PLC (AGN) reported stronger-than-expected revenue and a
smaller loss for the fourth quarter.
The maker of Botox and other drugs on Monday reported $4.35
billion in revenue for the quarter, up about 7% from the year
earlier and more than the $4.09 billion analysts polled by FactSet
predicted.
Allergan said its loss attributable to shareholders narrowed to
$317.2 million, or 97 cents a share, from $4.29 billion, or $12.83
a share, in the fourth quarter of 2018, when the company recorded
impairments, affecting results.
Allergan's adjusted earnings for the latest period of $5.22 a
share beat forecasts from analysts, who expected $4.57 a share on
that metric.
AbbVie Inc. (ABBV) plans on combining with Allergan in a deal
the companies believe will be completed in the first quarter.
Write to Micah Maidenberg at micah.maidenberg@wsj.com
(END) Dow Jones Newswires
February 10, 2020 07:31 ET (12:31 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024